FDA Guidance Provides Relief for MDR Reporting During a Pandemic
Exeed Regulatory Compliance
MARCH 22, 2020
Timely MDR reporting is a challenging regulatory requirement for the industry. In conclusion , this FDA guidance provides a much-needed relief during a pandemic to medical companies, importers and user facilities, such as hospitals, nursing homes and outpatient centers, from the strict MDR reporting requirements.
52 
Let's personalize your content